Showing results (261-270 of 1,945) with videos related to

Sort By:
Pageof 195
RMD Open|July 10, 2020
Predictors of extra-articular manifestations in axial spondyloarthritis and their influence on TNF-inhibitor prescribing patterns: results from the British Society for Rheumatology Biologics Register in Ankylosing SpondylitisMohammad H Derakhshan, Linda Dean, Gareth T Jones, et al.
RMD Open|November 4, 2022
Peripheral spondyloarthritis and psoriatic arthritis sine psoriase: are we dealing with semantics or clinically meaningful differences?Nelly Ziade, Michel Bou Absi, Xenofon Baraliakos
RMD Open|February 22, 2023
The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritisMaxime Dougados, Peter C Taylor, Clifton O Bingham, et al.
RMD Open|March 23, 2023
Risk of cancer in Korean patients with psoriatic arthritis: a nationwide population-based cohort studyYeonghee Eun, Jiwon Hwang, Gi Hyeon Seo, et al.
RMD Open|February 28, 2023
Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registersBenedicte Delcoigne, Tine Iskov Kopp, Elizabeth V Arkema, et al.
RMD Open|March 2, 2023
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease: an extension study (RESCUE 2)Ai Phuong Tran, D F Tassone, N S Ding, et al.
RMD Open|March 2, 2023
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi studyCéleste J T van der Togt, Bart Van den Bemt, Daniel Aletaha, et al.
RMD Open|March 17, 2023
Work participation in patients with axial spondyloarthritis: high prevalence of negative workplace experiences and long-term work impairmentUta Kiltz, Kirsten Hoeper, Ludwig Hammel, et al.
RMD Open|March 17, 2023
Patterns of clinical joint inflammation in juvenile idiopathic arthritisSascha L Heckert, Petra C E Hissink-Muller, J Merlijn van den Berg, et al.
RMD Open|May 7, 2021
Tofacitinib versus tocilizumab in the treatment of biological-naïve or previous biological-failure patients with methotrexate-refractory active rheumatoid arthritisShunsuke Mori, Yukitomo Urata, Tamami Yoshitama, et al.
Pageof 195